Liver disease does not affect lipolysis as measured with the 13C-mixed triacylglycerol breath test in children with cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 30, Issue 4, 2000, Pages 368-372

  Ling, Simon C ^a   Amarri, Sergio ^d   Slater, Christine ^a   Hollman, Anne S ^b   Preston, Tom ^c   Weaver, Lawrence T ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^d Yorkhill Hospitals ^*

Author keywords

Breath tests; Carbon isotopes; Dietary fats; Digestion; Liver disease

Indexed keywords

CARBON 13; TRIACYLGLYCEROL;

ARTICLE; BREATH ANALYSIS; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIGESTION; FEMALE; HUMAN; LIPOLYSIS; LIVER DISEASE; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL;

ADOLESCENT; BREATH TESTS; CARBON ISOTOPES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIETARY FATS; FEMALE; HUMANS; INFANT; INTESTINES; LIPOLYSIS; LIVER DISEASES; MALE; TRIGLYCERIDES;

EID: 0034119445     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200004000-00004     Document Type: Article

References (21)

1. Ling SC, Wilkinson JD, Hollman AS, McColl J, Evans TJ, Paton JY. The evolution of liver disease in cystic fibrosis. Arch Dis Child 1999;81:129-32.
2. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698-701.
3. Weizman Z, Durie PR, Kopelman HR, Vesely SM, Forstner GG. Bile acid secretion in cystic fibrosis: Evidence for a defect unrelated to fat malabsorption. Gut 1986;27:1043-8.
4. Tanner MS, Taylor CJ. Liver disease in cystic fibrosis. Arch Dis Child 1995;72:281-4.
5. Shiau Y-F. Lipid digestion and absorption. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 2nd ed. New York: Raven Press, 1987:1527-56.
6. Nagral AS, Joshi AS, Bhatia SJ, Abraham P, Mistry FP, Vora IM. Congestive jejunopathy in portal hypertension. Gut 1993;34: 694-7.
7. Robinson P, Sly P. High dose pancreatic enzymes in cystic fibrosis. Arch Dis Child 1990;65:311-2.
8. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1997;76:349-51.
9. Vantrappen GR, Rutgeerts PJ, Ghoos YF, Hiele MI. Mixed triglyceride breath test: A noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989;96:1126-34.
10. 13C: A comparison of oxidation after oral or parenteral administration in humans. J Nutr 1991;121:31-6.
11. Chow BPC, Shaffer EA, Parsons HG. Absorption of triglycerides in the absence of lipase. Can J Physiol Pharmacol 1990;68:519-23.
12. 14C. Effect of biliary and pancreatic flow diversion. J Clin Invest 1968;47:612-23.
13. Greenberger NJ, Rodgers JB, Isselbacher KJ. Absorption of medium and long chain triglycerides: Factors influencing their hydrolysis and transport. J Clin Invest 1966;45:217-27.
14. Linscheer WG, Castelli WP, Moore EW, Patterson JF, Chalmers TC. Absorption and plasma concentrations of octanoic acid in cirrhosis [abstract]. J Clin Invest 1964;43:1280.
15. 13C-breath tests to measure fat digestion. Br J Nutr 1998;79:541-5.
16. Williams SGJ, Evanson JE, Barrett N, Hodson ME, Boultbee JE, Westaby D. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol 1995;22:513-21.
17. 13C-labeled lipids: Trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology 1982;82:911-7.
18. 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. Arch Dis Child 1998;79:44-7.
19. Kalivianakis M, Minich DM, Bijleveld CMA, et al. Fat malabsorption in cystic fibrosis patients on enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 1999;69:127-34.
20. 13C] palmitic acid in healthy controls and patients with cystic fibrosis. Arch Dis Child 1997;76:425-7.
21. 14C palmitic acid by rat intestinal slices. Proc Soc Exp Biol Med 1965;120:468-72.